BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 35126518)

  • 1. Application Value of Serum Multi-Antibody Combined Detection in Differential Diagnosis and Typing of Lung Cancer.
    Cai T; Yao W; Liang F; Yang Q; Han F
    J Oncol; 2022; 2022():8944263. PubMed ID: 35126518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnostic and prognostic value of serum exosomal miR-1246 in non-small cell lung cancer.
    Huang D; Qu D
    Int J Clin Exp Pathol; 2020; 13(7):1601-1607. PubMed ID: 32782678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
    Zhang Y; Xu H
    J Clin Lab Anal; 2020 Jun; 34(6):e23237. PubMed ID: 32061007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer.
    Liu W; Liu J; Zhang Q; Wei L
    Cancer Biomark; 2020; 27(1):113-120. PubMed ID: 31771047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased serum exosomal miR-29a expression and its clinical significance in papillary thyroid carcinoma.
    Wen Q; Wang Y; Li X; Jin X; Wang G
    J Clin Lab Anal; 2021 Jan; 35(1):e23560. PubMed ID: 33368640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced circulating exosomal miR-382 predicts unfavorable outcome in non-small cell lung cancer.
    Luo R; Liu H; Chen J
    Int J Clin Exp Pathol; 2021; 14(4):469-474. PubMed ID: 33936369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer.
    Mao S; Lu Z; Zheng S; Zhang H; Zhang G; Wang F; Huang J; Lei Y; Wang X; Liu C; Sun N; He J
    J Exp Clin Cancer Res; 2020 Sep; 39(1):193. PubMed ID: 32958011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced serum exosomal miR-874 expression predicts poor prognosis in colorectal cancer.
    Zhang N; Zhang PP; Huang JJ; Wang ZY; Zhang ZH; Yuan JZ; Ma EM; Liu X; Bai J
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):664-672. PubMed ID: 32016967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum exosomal miR-7977 as a novel biomarker for lung adenocarcinoma.
    Chen L; Cao P; Huang C; Wu Q; Chen S; Chen F
    J Cell Biochem; 2020 Jun; 121(5-6):3382-3391. PubMed ID: 31898829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
    Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
    Zhang W; Su X; Li S; Liu Z; Wang Q; Zeng H
    Cancer Biomark; 2020; 27(4):485-491. PubMed ID: 32065786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
    Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M
    Oncology; 2018; 94(5):311-323. PubMed ID: 29533963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum exosomal miR-182 upregulation predicts unfavorable prognosis of esophageal squamous cell carcinoma.
    Qiu ML; Li X; Lin JB; Luo RG; Liu B; Feng Z
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5412-5418. PubMed ID: 32495876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma-Derived Exosomal microRNA-130a Serves as a Noninvasive Biomarker for Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
    He T; Guo X; Li X; Liao C; Wang X; He K
    J Oncol; 2021; 2021():5547911. PubMed ID: 33953745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating serum exosomal
    Lu X; Lu J; Wang S; Zhang Y; Ding Y; Shen X; Jing R; Ju S; Chen H; Cong H
    Future Oncol; 2021 Mar; 17(8):907-919. PubMed ID: 33533649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma.
    Wang J; Zhou Y; Lu J; Sun Y; Xiao H; Liu M; Tian L
    Med Oncol; 2014 Sep; 31(9):148. PubMed ID: 25099764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal miR-92b-3p Promotes Chemoresistance of Small Cell Lung Cancer Through the PTEN/AKT Pathway.
    Li M; Shan W; Hua Y; Chao F; Cui Y; Lv L; Dou X; Bian X; Zou J; Li H; Lin W
    Front Cell Dev Biol; 2021; 9():661602. PubMed ID: 34136482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.